Filing Flows

Filing Flows › Idexx Laboratories (IDXX) › Next earnings date

Idexx Laboratories (IDXX) earnings: beat the estimate

Idexx Laboratories (IDXX) reported on Nov 2, 2026 and beat the EPS estimate: $4.01 against $3.71 (+8.0%). Revenue was $1.2B for Q3 2026, +10% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+8.0% vs estimate
Beat rate100%

The last report

Idexx Laboratories reported revenue of $1.2B for the third quarter 2026 (+10% Y/Y), net earnings $317M: Product revenue $723M, Service revenue $491M. How it makes money → · Every quarter →

Idexx Laboratories: EPS against the estimate, last 5 reportsIdexx Laboratories: EPS against the estimate, last 5 reportsEstimateReported$3.15$3.40Nov 25$2.94$3.08Feb 26$3.41$3.47May 26$3.93$4.27Aug 26$3.71$4.01Nov 26
Latest (Nov 26): Estimate $3.71, Reported $4.01.
IDXX: the stock's move on each reportIDXX: the stock's move on each reportAug 4, 2026+3.0%May 5, 2026+2.9%Feb 2, 2026-5.7%Nov 3, 2025+14.7%

Idexx Laboratories' latest quarter

Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.

Questions

Did Idexx Laboratories beat earnings?

Idexx Laboratories (IDXX) reported on Nov 2, 2026 and beat the EPS estimate: $4.01 against $3.71 (+8.0%).

When does IDXX report earnings?

The next date is not set yet.

Does Idexx Laboratories usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.